Retour
48
Fourchette du Jour
324,93 €
334,23 €
Fourchette 52 Semaines
324,93 €
404,87 €
Volume
1 934 022
Moyenne 50J / 200J
363,32 €
/
372,67 €
Clôture Précédente
328,51 €
Quick Summary
Historique des Prix
Tendances Financières
Comparaison Sectorielle
vs médiane du secteur Healthcare (631 pairs)
| Métrique | Action | Médiane du Secteur |
|---|---|---|
| P/E | 38,6 | 0,2 |
| P/B | 5,6 | 3,0 |
| ROE % | 15,1 | 3,6 |
| Net Margin % | 12,9 | 3,8 |
| Rev Growth 5Y % | 10,1 | 10,0 |
| D/E | 0,7 | 0,2 |
Objectif de Cours des Analystes
Hold
428,67 €
+30.8%
Low: 390,00 €
High: 469,00 €
P/E Prévisionnel
21,82
BPA Prévisionnel
15,01 €
Croissance BPA (est.)
+0,0%
CA Est.
27,34B
Estimations de Bénéfices
| Période | BPA Est. | CA Est. | Analystes |
|---|---|---|---|
| FY2030 |
22,82 €
22,27 € – 23,20 €
|
37,93B | 2 |
| FY2029 |
21,03 €
20,52 € – 21,38 €
|
35,09B | 4 |
| FY2028 |
18,72 €
16,95 € – 20,12 €
|
32,17B | 6 |
No quarterly estimates available
Earnings Surprises
Last 8 quarters
| Quarter | Est. EPS | Actual EPS | Surprise |
|---|---|---|---|
| 2026-01-29 | 4,40 € | 4,47 € | +1,6% |
| 2025-10-30 | 3,13 € | 3,19 € | +1,9% |
| 2025-07-31 | 3,07 € | 3,13 € | +2,0% |
| 2025-05-01 | 2,71 € | 2,84 € | +4,8% |
| 2025-01-28 | 3,87 € | 4,01 € | +3,6% |
| 2024-10-29 | 2,77 € | 2,87 € | +3,6% |
| 2024-07-30 | 2,79 € | 2,81 € | +0,7% |
| 2024-04-30 | 2,35 € | 2,50 € | +6,4% |
Insider Trading Activity
18 transactions
| Date | Insider | Type | Shares | Price | Value |
|---|---|---|---|---|---|
| Mar 9, 2026 |
Lobo Kevin
Chair and CEO
|
grant | 50 332 | — | — |
| Mar 9, 2026 |
Menon Viju
Group President
|
grant | 9 320 | — | — |
| Mar 9, 2026 |
Stiles Spencer S
President and COO
|
grant | 14 912 | — | — |
| Feb 23, 2026 |
STRYKER RONDA E
Director
|
other | 55 600 | — | — |
| Feb 4, 2026 |
Fink M Kathryn
VP, Chief HR Officer
|
grant | 5 654 | — | — |
| Feb 4, 2026 |
King Debra
See Remarks
|
grant | 3 992 | — | — |
| Feb 4, 2026 |
Wells Preston Wendell
VP, Chief Financial Officer
|
grant | 11 974 | — | — |
| Feb 3, 2026 |
Stiles Spencer S
President and COO
|
other | 35 372 | 96,64 € | — |
| Nov 21, 2025 |
Pierce James Andrew
Group President
|
other | 422 | — | — |
| Nov 14, 2025 |
Berry William E Jr
VP, Chief Accounting Officer
|
other | 12 822 | 154,14 € | — |
| Nov 14, 2025 |
Berry William E Jr
VP, Chief Accounting Officer
|
sell | 1 953 | 365,49 € | 713 801,97 € |
| Aug 1, 2025 |
Montagnino Kimberly Ann
VP, Chief Comm. Officer
|
other | 155 | 392,73 € | 60 873,15 € |
| May 12, 2025 |
Berry William E Jr
VP, Chief Accounting Officer
|
sell | 1 241 | 388,56 € | 482 202,34 € |
| May 8, 2025 |
Caforio Giovanni
Director
|
grant | 560 | — | — |
| May 8, 2025 |
McCoy Sherilyn S
Director
|
grant | 560 | — | — |
| May 8, 2025 |
Suri Rajeev
Director
|
grant | 560 | — | — |
| May 8, 2025 |
Silvernail Andrew K
Director
|
grant | 560 | — | — |
| May 8, 2025 |
BRAINERD MARY K
Director
|
grant | 560 | — | — |
Dividend History
7 yr streakYield
0,01%
Payout Ratio
0,40%
Growth (3Y)
6,25%
Growth (5Y)
7,62%
| Ex-Date | Payment Date | Amount | Yield |
|---|---|---|---|
| Mar 31, 2026 | Apr 30, 2026 | 0,88 € | 1,05% |
| Dec 31, 2025 | Jan 30, 2026 | 0,88 € | 0,97% |
| Sep 30, 2025 | Oct 31, 2025 | 0,84 € | 0,91% |
| Jun 30, 2025 | Jul 31, 2025 | 0,84 € | 0,84% |
| Mar 31, 2025 | Apr 30, 2025 | 0,84 € | 0,88% |
| Dec 31, 2024 | Jan 31, 2025 | 0,84 € | 0,90% |
| Sep 30, 2024 | Oct 31, 2024 | 0,80 € | 0,89% |
| Jun 28, 2024 | Jul 31, 2024 | 0,80 € | 0,93% |
| Mar 27, 2024 | Apr 30, 2024 | 0,80 € | 0,86% |
| Dec 28, 2023 | Jan 31, 2024 | 0,80 € | 1,02% |
| Sep 28, 2023 | Oct 31, 2023 | 0,75 € | 1,10% |
| Jun 29, 2023 | Jul 31, 2023 | 0,75 € | 0,98% |
| Mar 30, 2023 | Apr 28, 2023 | 0,75 € | 1,03% |
| Dec 29, 2022 | Jan 31, 2023 | 0,75 € | 1,15% |
| Sep 29, 2022 | Oct 31, 2022 | 0,70 € | 1,35% |
| Jun 29, 2022 | Jul 29, 2022 | 0,70 € | 1,36% |
| Mar 30, 2022 | Apr 29, 2022 | 0,70 € | 0,98% |
| Dec 30, 2021 | Jan 31, 2022 | 0,70 € | 0,95% |
| Sep 29, 2021 | Oct 29, 2021 | 0,63 € | 0,94% |
| Jun 29, 2021 | Jul 30, 2021 | 0,63 € | 0,95% |
Points Clés
Revenue grew 10,07% annually over 5 years — strong growth
ROE of 15,08% — decent returns on equity
Generating 4,28B in free cash flow
P/E of 38,63 — premium valuation
Cash machine — converts 131,95% of earnings into free cash flow
Capital efficient — spends only 3,03% of revenue on capex
Croissance
Revenue Growth (5Y)
10,07%
Revenue (1Y)11,16%
Earnings (1Y)8,45%
FCF Growth (3Y)16,87%
Qualité
Return on Equity
15,08%
ROIC9,84%
Net Margin12,92%
Op. Margin19,47%
Sécurité
Debt / Equity
0,66
Current Ratio1,89
Interest Coverage8,05
Valorisation
P/E Ratio
38,63
Forward P/E21,82
P/B Ratio5,59
EV/EBITDA27,87
Dividend Yield0,01%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 11,16% | Revenue Growth (3Y) | 10,69% |
| Earnings Growth (1Y) | 8,45% | Earnings Growth (3Y) | 1,27% |
| Revenue Growth (5Y) | 10,07% | Earnings Growth (5Y) | 12,96% |
| Profitability | |||
| Revenue (TTM) | 25,12B | Net Income (TTM) | 3,25B |
| ROE | 15,08% | ROA | 6,78% |
| Gross Margin | 63,96% | Operating Margin | 19,47% |
| Net Margin | 12,92% | Free Cash Flow (TTM) | 4,28B |
| ROIC | 9,84% | FCF Growth (3Y) | 16,87% |
| Safety | |||
| Debt / Equity | 0,66 | Current Ratio | 1,89 |
| Interest Coverage | 8,05 | ||
| Dividends | |||
| Dividend Yield | 0,01% | Payout Ratio | 0,40% |
| Dividend Growth (3Y) | 6,25% | Dividend Growth (5Y) | 7,62% |
| Consecutive Div Years | 7 yrs | ||
| Valuation | |||
| P/E Ratio | 38,63 | Forward P/E | 21,82 |
| P/B Ratio | 5,59 | P/S Ratio | 4,99 |
| PEG Ratio | 5,16 | Forward PEG | N/A |
| EV/EBITDA | 27,87 | Fwd EV/EBITDA | 21,75 |
| Forward P/S | 4,59 | Fwd Earnings Yield | 4,58% |
| FCF Yield | 3,42% | ||
| Market Cap | 125,39B | Enterprise Value | 136,24B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 25,12B | 22,60B | 20,50B | 18,45B | 17,11B |
| Net Income | 3,25B | 2,99B | 3,17B | 2,36B | 1,99B |
| EPS (Diluted) | 8,40 | 7,76 | 8,25 | 6,17 | 5,22 |
| Gross Profit | 16,07B | 13,98B | 12,49B | 11,04B | 10,71B |
| Operating Income | 4,89B | 5,06B | 4,28B | 3,73B | 3,76B |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 47,84B | 42,97B | 39,91B | 36,88B | 34,63B |
| Total Liabilities | 25,42B | 22,34B | 21,32B | 20,27B | 19,75B |
| Shareholders' Equity | 22,42B | 20,63B | 18,59B | 16,62B | 14,88B |
| Total Debt | 14,86B | 14,12B | 13,49B | 13,53B | 12,90B |
| Cash & Equivalents | 4,01B | 3,65B | 2,97B | 1,84B | 2,94B |
| Current Assets | 14,76B | 14,85B | 12,52B | 10,28B | 10,02B |
| Current Liabilities | 7,79B | 7,62B | 7,92B | 6,30B | 4,55B |
Scores de Stratégies
This stock passed the criteria for 1 strategy
Score = fit strength (0–100)
Rank = position among all matches
Custom
Cash Flow Compounder
#437 of 1049
Activité Récente
Entré
Cash Flow Compounder
Mar 24, 2026